
Edarabid 1.5mg Injection is used to treat amyotrophic lateral sclerosis (a disease that weakens muscles and impairs function) and neurological damage caused by ischemic stroke. It also reduces nerve damage, slows disease progression, and protects brain cells by reducing oxidative stress after an ischemic strok
Vial
1.5mg
1 Vial
Store below 30°C
Store below 25°C
Intas Pharmaceuticals Ltd
International pharmaceutical standards compliant with WHO-GMP & GDP regulations
Procured strictly from audited, licensed global manufacturers with batch CoA authentication.
Active temperature logging during air cargo transit (refrigerated 2°C–8°C and CRT 15°C–25°C).
Pre-dispatch inspection, tamper-evident packing, and documentation verified by licensed pharmacists.
Amyotrophic lateral sclerosis (ALS)
Neuroprotective Agent in Ischemic stroke
Stroke
At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.
All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.
All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.
"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."
Essential information on active composition, WHO-GMP quality compliance, cold-chain storage, and international export.
Edarabid 1.5mg Injection is a certified pharmaceutical product formulated as a Vial (1.5mg). It contains the active pharmaceutical ingredient Edaravone (1.5mg), manufactured by Store below 25°C.
Edarabid 1.5mg Injection is manufactured by Store below 25°C complying with strict WHO-GMP / international quality standards. ExSell Laboratories supplies authentic batches accompanied by manufacturer Certificate of Analysis (COA) and complete regulatory documentation.
Edarabid 1.5mg Injection must be stored according to manufacturer instructions: Store below 30°C. ExSell Laboratories utilizes validated temperature-controlled cold-chain packaging for international transit.
Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.
Other certified pharmaceutical brands formulated with Edaravone (1.5mg).

Edaravone (1.5mg)

Edaravone (1.5mg)

Edaravone (1.5mg)

Edaravone (1.5mg)
Edarabid 1.5mg Injection
1.5mg